Ledger.Open graph →
SEC Form D · filed January 4, 2019

Pear Therapeutics, Inc

Offering
$65.0M
Sold
$64.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Zack Lynch · Boston, MADirectorYuri Maricich · Boston, MAExecAndrew Schwab · Boston, MADirectorCorey Mccann · Boston, MAExec · DirectorTimothy Petersen · Boston, MADirectorChristopher Guiffre · Boston, MAExecHongjie Hu · Boston, MADirectorJamie Star · Boston, MADirectorJason Fitzgerald · Boston, MADirectorMichael T. Willner · Westport, CTExecJohn D'Agostino · Boston, MAExec · DirectorEdward T. Minskoff · Westport, CTExecAION Value Add II GP LLC · New York, NYDirectorJeremy Gilbert · Boston, MAExecAlex Waldron · Boston, MAExecMichael Blitzer · New York, NYDirectorGuy Shanon · New York, NYDirectorVerena A. Lim · Singapore, U0Exec · DirectorDavid A. Baldwin · Singapore, U0DirectorChristopher E. Low · Singapore, U0ExecGeoff Ruddick · Grand Cayman, Cayman IslandsExecJeremy Gilbert · Boston, MAExecAlex Waldron · Boston, MAExecHongjie Hu · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗